<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 19 Aug 2026 16:05:16 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
 </channel>
</rss>
